Leadership at the Centers for Medicare and Medicaid Services is working with states to develop plans to use the $50 billion ...

Dr. Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services, discusses the Trump administration’s efforts ...

In an exclusive interview with Yahoo Finance's Decoding Retirement podcast, Mehmet Oz, the administrator of the Centers for ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

The latest public gaffe came as the Trump administration is encouraging millions of Americans to transfer their personal ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so.

President Donald Trump looked as though he was on the verge of falling asleep as a key member of his administration helped ...

Dr. Oz tells Americans on Medicaid ‘don’t eat carrot cake’ as millions face health insurance cuts - ‘Do the most you can do to really live up to your God-given potential to live a full and healthy ...

Dr. Mehmet Oz is the administrator of the Centers for Medicare & Medicaid Services. Kim Brandt is the deputy administrator and chief operating officer.